News

Anticipating Littelfuse's Upcoming Earnings Report Insights

Anticipating Littelfuse's Upcoming Earnings Report Insights

Understanding Littelfuse's Earnings Expectations

Littelfuse (NASDAQ: LFUS) is set to release its quarterly earnings soon. Investors are eagerly awaiting the announcement to uncover how the company is performing amidst market challenges and opportunities.

Projected Earnings Performance

Analysts predict Littelfuse will report an impressive earnings per share (EPS) of $2.34, a figure investors hope will be surpassed. Guidance beyond the EPS figure is critical as it often influences stock pricing in subsequent trading sessions.

Insights from Past Earnings Reports

Looking back at previous quarters, Littelfuse has shown a tendency to beat EPS expectations. For instance, last quarter, the company exceeded estimates by $0.38, which positively influenced their stock price with a 1.75% increase the following day.

A Snapshot of Prior Earnings

Here's a brief overview of the company's earnings over the last few quarters, detailing their projected and actual EPS along with corresponding price changes:

Quarter Q1 2025 Q4 2024 Q3 2024 Q2 2024
EPS Estimate 1.81 2.06 2.09 1.75
EPS Actual 2.19 2.04 2.71 1.97
Price Change % 2.0% 5.0% -3.0% 3.0%

Current Market Performance

As of July 28, Littelfuse shares are valued at $237.17. Over the course of the last year, the stock has experienced a decline of 11.88%. This trend reflects a challenging landscape, particularly concerning long-term investors who may feel anxious as the earnings release approaches.

Analyst Perspectives on Littelfuse

Expert analysis remains vital for potential investors in Littelfuse, as it helps gauge market sentiment towards the company's prospects. Presently, the consensus rating for Littelfuse is Neutral, supported by two analyst ratings and an average price target set at $234.5, implying a slight downside risk of about 1.13%.

Comparative Ratings with Industry Peers

To better understand Littelfuse’s positioning, it’s essential to compare its analyst ratings with those of competitors such as Belden, Knowles, and Bel Fuse:

  • Belden is viewed favorably, showing a Buy rating with a target price of $125.0, suggesting a 47.3% upside.
  • Knowles also holds a Buy rating, with an enticing target price of $22.0, hinting at a potential 90.72% upside.
  • Bel Fuse has an Outperform rating with a target of $113.25, suggesting a possible 52.25% upside.

Peer Analysis in the Industry

Key metrics shed light on how Littelfuse stacks up against its peers:

Company Consensus Revenue Growth Gross Profit Return on Equity
Littelfuse Neutral 3.53% $207.26M 1.79%
Belden Buy 16.65% $245.84M 4.13%
Knowles Buy 10.36% $53.30M 1.04%
Bel Fuse Outperform 10.55% $58.82M 7.66%

Key Takeaways from the Analysis

In this competitive overview, Littelfuse shows a moderate consensus rating. While it trails in revenue growth and gross profit compared to its peers, it excels in Return on Equity, indicating efficient resource utilization.

A Closer Look at Littelfuse

Littelfuse stands out as a leading provider of circuit protection solutions—including fuses and relays—across various markets, such as transportation and industrial sectors. Additionally, the company is making strides in the power semiconductor market and is entering the electric vehicle charging space. With a dedicated workforce of 17,000, Littelfuse is positioned for further growth.

The Economic Impact of Littelfuse: A Comprehensive Overview

Market Capitalization Context: The market capitalization of Littelfuse indicates it is somewhat smaller than its industry benchmarks, suggesting there may be reasons linked to growth prospects or operational efficiency.

Revenue Growth Trend: In the last three months, Littelfuse achieved a noteworthy revenue growth rate of 3.53%, reflecting a positive ascent in its overall financials. However, the growth remains below the average growth rates within the Information Technology sector.

Net Margin Analysis: A solid net margin of 7.86% positions Littelfuse above industry averages, showcasing effective cost management and profitability.

Return on Equity (ROE): Littelfuse delivers a favorable ROE of 1.79%, further indicating the strategic management of equity capital.

Effective Use of Assets: The company enjoys a Return on Assets (ROA) of 1.12%, showcasing effective utilization in generating returns from its assets.

Debt Management Efficiency: Littelfuse maintains a conservative debt-to-equity ratio of 0.36, suggesting a stable financial footing.

Frequently Asked Questions

What is Littelfuse's projected earnings for the upcoming quarter?

Littelfuse is expected to report an EPS of $2.34 for the upcoming quarter.

How has Littelfuse performed in previous earnings?

In the last quarter, Littelfuse beat EPS estimates by $0.38, resulting in a share price increase of 1.75% the following day.

What is the stock performance of Littelfuse as of the latest data?

Littelfuse shares were trading at $237.17, with a 52-week decline of 11.88%.

What is the consensus rating for Littelfuse?

The consensus rating for Littelfuse among analysts is Neutral, with a price target of $234.5.

What markets does Littelfuse operate in?

Littelfuse is a significant player in circuit protection solutions for transportation, industrial sectors, telecommunications, and consumer electronics.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 6

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading

Top 5 Most Recently Viewed Articles

Auburn National Bancorporation's Earnings Surge in Q3

Updated Category News Views 32

Auburn National Bancorporation's Q3 Earnings Overview Auburn National Bancorporation, Inc. recently announced its financial results for the third quarter of 2024. The report highlighted significant improvements in key financial metrics compared to the same quarter last year. Financial Performance Highlights For the third quarter of 2024, Auburn National Bancorporation...

Continue Reading
NEO Battery Innovations: Stock Options for Future Growth

Updated Category News Views 211

NEO Battery Materials Grants Incentive Stock Options TORONTO — NEO Battery Materials Ltd. (“NEO” or the “Company”) (TSX-V: NBM) (OTC: NBMFF), known for pioneering low-cost silicon anode materials, has recently announced the granting of incentive stock options to several of its directors and officers. This move allows them to acquire a total of 510,000 common...

Continue Reading
Zventus Partners with TecNM to Enhance Software Development Skills

Updated Category News Views 224

Introduction to a New Era in Software Development In a significant collaboration aimed at enhancing software development capabilities, Zventus, a prominent global consulting firm, has joined forces with the Ensenada Institute of Technology. This partnership marks an important milestone in connecting academic learning with crucial industry needs. The Purpose Behind the...

Continue Reading
Robert Reich Critiques Trump's Tax Plans and Corporate Gains

Updated Category News Views 575

Robert Reich's Perspective on Proposed Tax Cuts Renowned economist and former U.S. Secretary of Labor Robert Reich has voiced strong concerns regarding the tax reduction proposals from the administration led by Donald Trump. In a recent statement, Reich described the intended cuts as "an absolutely shameless giveaway" that could potentially escalate the federal deficit by...

Continue Reading
Eli Lilly Boosts Infectious Disease Strategy in 2026

Updated Category News Views 11

What's Eli Lilly Cooking Up? So, Eli Lilly is throwing some serious chips on the table with these new acquisitions. The pharma giant is snapping up not one, not two, but three companies—all to bolster its infectious disease game. Now, if you've been around the market block as long as I have, you know they aren't just doing this for fun. It's about strategic positioning,...

Continue Reading